JPS6011892B2 - Method for producing interferon inducer - Google Patents

Method for producing interferon inducer

Info

Publication number
JPS6011892B2
JPS6011892B2 JP54013024A JP1302479A JPS6011892B2 JP S6011892 B2 JPS6011892 B2 JP S6011892B2 JP 54013024 A JP54013024 A JP 54013024A JP 1302479 A JP1302479 A JP 1302479A JP S6011892 B2 JPS6011892 B2 JP S6011892B2
Authority
JP
Japan
Prior art keywords
activity
inducer
extract
active substance
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54013024A
Other languages
Japanese (ja)
Other versions
JPS55115893A (en
Inventor
保彦 小島
精之 金野
喬 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KITAZATO KENKYUSHO
Original Assignee
KITAZATO KENKYUSHO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KITAZATO KENKYUSHO filed Critical KITAZATO KENKYUSHO
Priority to JP54013024A priority Critical patent/JPS6011892B2/en
Priority to DE19803004018 priority patent/DE3004018A1/en
Priority to BE0/199303A priority patent/BE881595A/en
Priority to GB8004156A priority patent/GB2042558B/en
Priority to FR8002649A priority patent/FR2448350A1/en
Publication of JPS55115893A publication Critical patent/JPS55115893A/en
Priority to IN144/CAL/81A priority patent/IN152883B/en
Publication of JPS6011892B2 publication Critical patent/JPS6011892B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)

Description

【発明の詳細な説明】 本発明は植物の組織から単離されたインターフェロン(
以下IFという)譲起剤の製法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides interferon (
The present invention relates to a method for producing an promoting agent (hereinafter referred to as IF).

本発明は、優れたIF譲起活性を有する物質が、キク科
ベニバナ属に属する各種植物またはその変員の組織に含
まれ、そしてこの活性物質を単に安価に単離することが
できるという知見に基いている。従って本発明の目的は
、優れたIF談起活性と低い毒性とをもちかつ簡単に安
価に製造することのできるIF誘起剤の製法を提供する
ことにある。
The present invention is based on the knowledge that a substance having excellent IF-inducing activity is contained in the tissues of various plants belonging to the genus Safflower of the Asteraceae family, or its variants, and that this active substance can be simply isolated at a low cost. It is based. Therefore, an object of the present invention is to provide a method for producing an IF inducer that has excellent IF inducing activity and low toxicity and can be produced simply and at low cost.

本発明により、無定形白色状粉末の状態において安定で
IF誘起活性および下記の理化学的特性を有する物質が
提供される。
The present invention provides a substance that is stable in the form of an amorphous white powder, has IF-inducing activity, and has the following physicochemical properties.

凶 理化学的特性 【1} 元素分析 H:6.54±0.3%、C:41.9±0.3%、N
:2.39±0.3%、P:0.28±0.03%【2
’分子量約10万なし、し約300万(主として約50
万ないし100万)〔スピンコ・モデルE分析用超遠心
機(米国べックマン社製)使用の超遠心法、アミコン限
外炉過機およびXM50、XMIOOAおよびXM30
G戸過膜(米国アミコン社製)UKI0、UK50およ
びUK20の戸過膜(東洋炉紙製)使用の限外炉過法、
およびセフアデックスG−200(スエーデン国、ファ
ーマシア・ファイン・ケミカルAB製)使用のゲル炉過
法により測定〕{3} 融点または分解点 融点不明確。
Physical and chemical properties [1] Elemental analysis H: 6.54 ± 0.3%, C: 41.9 ± 0.3%, N
:2.39±0.3%, P:0.28±0.03% [2
'Molecular weight: approximately 100,000, approximately 3,000,000 (mainly approximately 50,000)
10,000 to 1,000,000) [Ultracentrifugation method using Spinco Model E analytical ultracentrifuge (manufactured by Beckman, USA), Amicon ultrafurnace filtration machine and XM50, XMIOOA and XM30
Ultrafurnace filtration method using G door filter membrane (manufactured by Amicon, USA) UKI0, UK50 and UK20 door filter membrane (manufactured by Toyo Paper),
and measured by gel filtration method using Sephadex G-200 (manufactured by Pharmacia Fine Chemical AB, Sweden)] {3} Melting point or decomposition point Melting point unclear.

約220qoで炭化する。■ 紫外線吸収スペクトル 第1図の通り(0.1NNaOH中で測定したが「水ま
たはINNaOH中でも変化しなかった)で約250お
よび280の仏に肩を示す。
Carbonizes at about 220 qo. ■ Ultraviolet absorption spectrum as shown in Figure 1 (measured in 0.1N NaOH, but did not change in water or INNaOH) showing shoulders at about 250 and 280 degrees.

(5ー 赤外線吸収スペクトル第2図の通り(KBr法
) ■ 各種溶剤中の溶解性 水に溶解し、水酸化ナトリウム、水酸化カリウム、水酸
化アンモニウム等のアルカリ性水溶液にとくによく溶解
する。
(5- Infrared absorption spectrum as shown in Figure 2 (KBr method) ■ Solubility in various solvents Dissolves in water, particularly well in alkaline aqueous solutions such as sodium hydroxide, potassium hydroxide, and ammonium hydroxide.

メタノール、エタノール、フ。ロィぐノール「 ブタノ
ール、アセトン、クロロホルム、エーテルに難溶である
。‘7’呈色反応 ニンヒドリン反応、フェノール/硫酸反 応、フオリン試薬およびディツトマー反応に陽‘性。
Methanol, ethanol, fu. Low Solubility: Slightly soluble in butanol, acetone, chloroform, and ether.Positive to ninhydrin reaction, phenol/sulfuric acid reaction, phorin reagent, and ditzmer reaction.

ェルソン・モーガン反応に陰性。Negative for the Gelson-Morgan test.

【8} 性質 酸性 ■ 主な化学組成 …アミノ酸 オキシプロリン (15.61±0.4%)アス
パラギン酸 (5.51±0.4%)スレオニ
ン (10.90±0.4%)セリン
(9.64土0.4%)グルタミン酸
(3.96土0.4%)プロリン
(4.27±0.4%)グリシン (9
.09±0.4%)アラニン (8.2
4土0.4%)バリン (4.04±0
.4%)イソロイシン (5.59土0.4
%)ロイシン (2.56±0.4%)フ
エニールアラニン (1.32±0.4%)リジン
(2.18土0.4%)アルギニン
(1.24±0.4%)チロシン
(1.94±0.4%)ヒスチジン
(0.93±0.4%)アンモニア (12・
98土0.4%)(磯塩酸で110qCで4錨時間減圧
下に加水分解後、米国テクニコン社製、テクニコン・ア
ミノ酸オ−トアナライザーNC−1型で分析した) ‘o}糖 アラビノース (9.38±0,6%)ガラク
トース (20.98±0.6%)グルコース
(64.98±0.6%)マンノース
(3.26±0.6%)キシロース
(1.40±0.6%)(0.1N硫酸で80℃で
20分間およびIN硫酸で100ooで2時間それぞれ
加水分解後、米国テクニコン社製、テクニコン糖オート
アナライザーN−1型で分析した)肌 比旋光度 〔Q〕容=十630〜十69o平均+66o(濃度0.
49%、0.1NNaOH中){B} 生物学的特性 m m誘起活性 本発明によるIF誘起剤の試料を用いて試験動物の細胞
および血清中にIFを議起し、その活性を後記試験例記
載の方法で測定した結果は第1表および第2表の通りで
、IF譲超活性が認められた。
[8} Acidic nature■ Main chemical composition...amino acids oxyproline (15.61±0.4%) aspartic acid (5.51±0.4%) threonine (10.90±0.4%) serine
(9.64 soil 0.4%) glutamic acid
(3.96 soil 0.4%) Proline
(4.27±0.4%) Glycine (9
.. 09±0.4%) Alanine (8.2
4 soil 0.4%) Valine (4.04±0
.. 4%) Isoleucine (5.59 soil 0.4
%) Leucine (2.56±0.4%) Phenylalanine (1.32±0.4%) Lysine
(2.18 soil 0.4%) arginine
(1.24±0.4%) Tyrosine
(1.94±0.4%) Histidine
(0.93±0.4%) Ammonia (12.
98 Soil 0.4%) (Hydrolyzed with isohydrochloric acid at 110 qC for 4 hours under reduced pressure and analyzed with Technicon Amino Acid Auto Analyzer Model NC-1 manufactured by Technicon, USA) 'o} Sugar arabinose (9 .38±0.6%) Galactose (20.98±0.6%) Glucose
(64.98±0.6%) Mannose
(3.26±0.6%) xylose
(1.40±0.6%) (After hydrolysis with 0.1N sulfuric acid at 80°C for 20 minutes and IN sulfuric acid at 100°C for 2 hours, analysis was performed using Technicon Sugar Autoanalyzer Model N-1, manufactured by Technicon, USA. ) Skin Specific rotation [Q] Volume = 1630 to 169o average + 66o (concentration 0.
49% in 0.1 N NaOH) {B} Biological properties m m Induced activity A sample of the IF inducer according to the present invention was used to induce IF in the cells and serum of a test animal, and its activity was measured in the test example below. The results measured by the method described are shown in Tables 1 and 2, and IF-transferring superactivity was observed.

第1表 2頭のウサギを用いて、後記試験例記載の方法で得た結
果は第2表の通りで、2頭ともに投与後2時間で最大の
活性に達した。
The results obtained using the method described in the test example below using the two rabbits in Table 1 are as shown in Table 2, and the maximum activity was reached in both rabbits 2 hours after administration.

第2表 後記試験例記載の方法により、本発明によるIF譲起剤
の作用で試験動物の体内にIFが誘起されたことが認め
られる。
It was confirmed that IF was induced in the test animals' bodies by the action of the IF-inducing agent according to the present invention by the method described in the Test Examples below in Table 2.

2)ぽ誘起活性の安定性 本発明によるび誘起剤の試料(各1の夕)を水(各1の
【)に溶解し、100℃で所定時間または所定温度で1
時間それぞれ加熱した後、各試料を試験例1記載のィン
・ビートロ法に準じて活性を測定した結果は第3表およ
び第4表の通りであって、本発明によるIF譲起剤は熱
に安定であることが認められた。
2) Stability of poly-induced activity A sample of the poly-inducing agent according to the present invention (1 serving each) was dissolved in water (1 serving each), and the mixture was incubated at 100°C for a predetermined time or at a predetermined temperature.
After heating for each time, the activity of each sample was measured according to the in vitro method described in Test Example 1. The results are shown in Tables 3 and 4. It was found to be stable.

第3表 (注)加熱時間:1時間 第4表 (注) 加熱温度100℃ (3} 急性毒性 オスおよびメスのマウス(ddy系、5週令、体重20
土1夕、各群10匹)を試験動物とした。
Table 3 (Note) Heating time: 1 hour Table 4 (Note) Heating temperature 100°C (3) Acutely toxic male and female mice (ddy strain, 5 weeks old, weight 20
(10 animals in each group) were used as test animals.

生理的食塩水に溶解した本発明によるIF誘起剤を、マ
ウス腹腔内または経口投与した結果、LD5。値は>1
.5夕/kg(腹腔)および>10タ′k9(経口)で
あり、メスとオスとの間に著差はなかった。【4} 抗
腫湯活性 マウス(ddy系、5週令、体重20±1夕、各群10
匹)を試験動物とし、S−180ザルコーマ固型腫湯(
2×2×2帆)またはヱーリッヒ腹水がん(2.5×1
ぴ個)をマウスの豚喬に移植し、24時間後に本発明に
よるIF誘起剤(0.2雌含有)水溶液を各マウスに毎
日1回経口投与し、14日間続けた。
LD5 as a result of intraperitoneal or oral administration of the IF inducer of the present invention dissolved in physiological saline to mice. Value is >1
.. 5 g/kg (peritoneal) and >10 g/kg (oral), with no significant difference between females and males. [4] Anti-tumor active mice (ddy strain, 5 weeks old, body weight 20 ± 1 night, 10 in each group
S-180 Sarcoma solid tumor (
2 x 2 x 2 sails) or Erich ascites cancer (2.5 x 1
After 24 hours, an aqueous solution of the IF inducer of the present invention (containing 0.2 females) was orally administered to each mouse once a day for 14 days.

抗腫蕩性が認められた。上記の特性から、本発明による
物質は、アミ/酸、糖、リン酸を主体とする分子量約1
0万から約300万(主として約50万から約100方
)の高分子を有し、リン酸を含有する糖と蛋白質の複合
体であると思われる。
Antitumor properties were observed. From the above characteristics, the substance according to the present invention has a molecular weight of about 1
It is thought to be a complex of sugar and protein containing phosphoric acid and having a polymer of 0,000 to about 3,000,000 molecules (mainly about 500,000 to about 100 molecules).

またこの物質によって動物の体内または試験管内に誘起
されたIFは、トリプシン(0.08%、370、2時
間)で失活するばかりでな〈、動物種特異性とウイルス
種非特異I性とを有しているので、本物質は一般に認め
られているm誘起剤の定義に該当する物質であることが
わかった。本発明による物質と同様な理化学的および生
物学的特性を有する物質は知られていないから、本物質
は新規物質であり、新親び誘起剤である。
Furthermore, IF induced in animals or in vitro by this substance is not only inactivated by trypsin (0.08%, 370, 2 hours), but also has animal species-specificity and virus species-nonspecificity. It was found that this substance falls under the generally accepted definition of an m-inducing agent. Since no substance is known that has similar physicochemical and biological properties to the substance according to the invention, this substance is a new substance and a novel affinity-inducing agent.

すなわち公知のフイトヘマグルチニン、アメリカヤマゴ
ボウ・マイトージエンおよびコンカナバリンAのような
植物凝集素は公知文献の記載によると、分子量10方以
上の蛋白質で、5600で1時間または6000で5時
間加熱すると、IF誘起活性を失なうばかりでなく、こ
れらのIF誘起活性は非常に弱い。これに対して、本発
明によるIF誘起剤は、化学組成が異なる点、1000
0で数時間加熱しても安定である点、およびIF誘起活
性が高い点等において植物凝集素と区別される。次に当
帰の根から得られた公知のIF誘起剤は10万以上の高
分子物質で、100qoで1時間加熱しても失活しない
が、その化学組成(ヘキソース、48%、ウロン酸40
%、蛋白質5%)および赤外線吸収スペクトルが異なる
ことによって、本発明によるIF誘起剤と区別される。
またクワの根皮から得られたIF誘起剤は、分子量2万
以上(主に6万以上)で1−3結合グルコース(ヘキソ
ース96%を含む)を主体としているから、本発明によ
るIF譲起剤と区別される。
That is, known plant agglutinins such as phytohemagglutinin, pokeweed mitogen, and concanavalin A are proteins with a molecular weight of 10 or more, and when heated at 5600 for 1 hour or 6000 for 5 hours, they induce IF. Not only do they lose activity, but their IF-induced activity is very weak. In contrast, the IF inducer according to the present invention has a different chemical composition, 1000
It is distinguished from plant agglutinins in that it is stable even when heated at zero for several hours, and that it has high IF-inducing activity. Next, the known IF inducer obtained from Toki root is a polymer substance with a molecular weight of more than 100,000 and does not become inactive even when heated at 100 qo for 1 hour, but its chemical composition (hexose, 48%, uronic acid, 40%
%, protein 5%) and infrared absorption spectra distinguish it from the IF inducers according to the invention.
Furthermore, since the IF inducer obtained from the root bark of mulberry has a molecular weight of 20,000 or more (mainly 60,000 or more) and is mainly composed of 1-3 linked glucose (containing 96% hexose), the IF inducer according to the present invention can be distinguished from agents.

本発明によるIF誘起剤の製造原料であるキク料ベニバ
ナ属植物に含有されるカルタミン、カルタモン、ネオカ
ルタミン等はIF誘起活性を有しない低分子物質で、本
発明によるIF誘起剤と理化学的特性が異なっている。
本発明によるIF誘起剤は、公知の植物の組織から単離
されたIF誘起剤よりも優れたIF誘起活性を有し、動
物に経口投与した場合の急性毒性は非常に低く、抗腫傷
活性を有しているので、ヒトおよび動物における発がん
型ウイルスのようなウイルス感染症の予防および治療用
として期待される。
Cartamine, cartamone, neocartamine, etc. contained in chrysanthemum plants of the genus Safflower, which are the raw materials for producing the IF inducer according to the present invention, are low-molecular substances that do not have IF-inducing activity and have different physical and chemical properties from the IF inducer according to the present invention. ing.
The IF inducer according to the present invention has superior IF inducer activity than known IF inducers isolated from plant tissues, has very low acute toxicity when orally administered to animals, and has antitumor activity. Therefore, it is expected to be used for the prevention and treatment of viral infections such as carcinogenic viruses in humans and animals.

本発明により提供されるIF誘起剤の製造方法は、キク
科(Compositae)ベニバナ属(Canham
雌)またはその変員に属しかつIF誘起活性物質を含有
する植物の組織から、上記活性物質を抽出し、抽出物か
らこれを回収することを特徴としている。
The method for producing an IF inducer provided by the present invention is directed to
The method is characterized in that the above-mentioned active substance is extracted from the tissue of a plant that belongs to the IF-inducing active substance (Female) or its mutants and contains the IF-inducing active substance and is recovered from the extract.

本発明の方法に使用される植物は世界各国に豊富に栽培
または自生している植物で、自然または人工的に突然変
異体や雑壁のような変員(Variant)を形成する
傾向がある。
The plants used in the method of the present invention are plants that are abundantly cultivated or grow naturally in various countries around the world, and tend to naturally or artificially form mutants or variants such as miscellaneous walls.

各国産の多くのベニバナ属植物およびそれらの変員を本
発明の目的に実用できることがわかった。下記の植物は
例示にすぎない。ベニバナ(Ca比ham船tinct
oriusLinne)アレチベニバナ(Caれham
順lanat順Linne)Canham順 arbo
reSCenSCartham低 baetjC聡 N
ymanベニバナは黄および紅色素の原料として、また
食用油の原料として長年の間各国で栽培され、日本およ
び中国では薬草として用いられている。
It has been found that many plants of the genus Safflower and their variables from various countries can be used for the purpose of the present invention. The plants listed below are illustrative only. Safflower tinct
oriusLinne) Careham (Careham)
Order lanat order Linne) Canham order arbo
reSCenSCartham low baetjC Satoshi N
Yman safflower has been cultivated in various countries for many years as a raw material for yellow and red pigments and as a raw material for edible oil, and is used as a medicinal herb in Japan and China.

本発明の方法の原料として新鮮な植物を用いてもよいが
、保存上および抽出効率の点から乾燥し套警護串墨ら義
、蚤釜藁雲容至るき霞富豪湊袋隼音てもよい。抽出は一
般に水で任意温度(たとえば室温から抽出混合物の沸騰
まで)で行なうことができる。
Fresh plants may be used as raw materials for the method of the present invention, but from the standpoint of preservation and extraction efficiency, dried plants may also be used. . Extraction can generally be carried out with water at any temperature (eg, from room temperature to boiling of the extraction mixture).

本発明による物質はアルカリ性の水溶液(例、pH7−
10)によく溶けるので、公知の緩衝液や水酸化ナトリ
ウム、水酸化カリウム、水酸化アンモニウム等を用いて
、抽出時に水のpHを調整するとよい。抽出時間は任意
であるが、室温では通常1一5日である。抽出温度が高
いと抽出時間は短縮される(たとえば40−100午0
で30分から6時間)。本発明の方法によって、植物の
組織に含まれた活性成分の大部分(場合により90%以
上)を抽出することができる。所望により、抽出時に適
当な防腐剤を加えることもできる。抽出は連続式でもバ
ッチ式でもよい。抽出水と原料との比は任意である。ま
たは、メタノール、エタノ−ル、ブロパノール、ブタノ
ール「ジメチルスルフオキシド、アセトンのような親水
性有機溶剤の適当な濃度(たとえば20−80%)で植
物組織から活性物質を抽出してもよい。この場合温度と
時間は任意でよい(たとえば40−80qoで4時間な
いし2日間)。炉過、圧搾または遠心分離のような常法
により、抽出液から植物の残澄を除去し、こうして得ら
れた抽出液から低分子物質、色素等の不活性成分を除き
、活性成分を回収する。 このための実用的な方法の例
は次の通りである。凶 本発明によるIF誘起剤の活性
成分は、分子量約10万以上約300万以下(主として
約50万なし・し100万)の物質を含む部分に存在す
るから、分画分子量10万以上の物質を分別できる適当
な膜を用いた眼外炉過法で上燈液を処理する。
The substances according to the invention can be used in alkaline aqueous solutions (e.g. pH 7-
10), it is recommended to adjust the pH of the water during extraction using a known buffer solution, sodium hydroxide, potassium hydroxide, ammonium hydroxide, etc. Although the extraction time is arbitrary, it is usually 1-5 days at room temperature. If the extraction temperature is high, the extraction time will be shortened (e.g. 40-100 pm).
(30 minutes to 6 hours). By the method of the present invention, most of the active ingredients contained in plant tissues (90% or more in some cases) can be extracted. If desired, a suitable preservative can be added during extraction. Extraction may be continuous or batchwise. The ratio of extraction water to raw material is arbitrary. Alternatively, the active substance may be extracted from the plant tissue with a suitable concentration (e.g. 20-80%) of a hydrophilic organic solvent such as methanol, ethanol, propanol, butanol, dimethyl sulfoxide, acetone. In this case, the temperature and time may be arbitrary (for example, 4 hours to 2 days at 40-80 qo).The plant residue is removed from the extract by a conventional method such as filtration, squeezing, or centrifugation. The active ingredients are recovered by removing inactive ingredients such as low molecular weight substances and pigments from the extract. Examples of practical methods for this purpose are as follows.The active ingredients of the IF inducer according to the present invention are: Since it exists in the part containing substances with a molecular weight of about 100,000 to about 3 million (mainly about 500,000 to 1,000,000), an extraocular furnace using an appropriate membrane that can separate substances with a cutoff molecular weight of 100,000 or more is necessary. Treat the upper light solution using the method.

限外炉過の圧力はたとえば0.1一5k9/地とするこ
とができる。こうして得られた活性部分を集めて、凍結
乾燥すると褐色の粉末が得られる。
The pressure in the ultrafurnace can be, for example, 0.1-5k9/ground. The active moieties thus obtained are collected and lyophilized to yield a brown powder.

‘B} 抽出液を所望により減圧下で濃縮し、親水性有
機溶剤(たとえばメタノール、エタノール、プロパノー
ル、ブタノール、アセトン等)を抽出液またはその濃縮
液に適当な濃度(たとえば40−7帆八%)になるよう
に加えると、活性成分を含む沈殿物が生じるので、これ
を減圧下に乾燥すると、褐色の粉末が得られる。
'B} The extract is concentrated under reduced pressure if desired, and a hydrophilic organic solvent (e.g., methanol, ethanol, propanol, butanol, acetone, etc.) is added to the extract or its concentrate at an appropriate concentration (e.g., 40-7%). ), a precipitate containing the active ingredient is formed, which is dried under reduced pressure to obtain a brown powder.

に’上記の有機溶剤の代わりに、塩化アンモニウム、硫
酸アンモニウム、セチルトリメチルアンモニウムプロミ
ドのようなアンモニウム塩または塩化亜鉛、塩化鋼のよ
うな無機金属塩を適当な濃度(たとえば20‐5肌/v
%)になるように加えると、活性成分を含む沈殿物が生
じるので、沈殿物をたとえばセルロースチューブで透析
するか、分画分子量1万の膜で限外炉過するかにより脱
塩後、乾燥すると、褐色の粉末が得られる。
Instead of the organic solvents mentioned above, ammonium salts such as ammonium chloride, ammonium sulfate, cetyltrimethylammonium bromide or inorganic metal salts such as zinc chloride, steel chloride can be added at appropriate concentrations (e.g. 20-5 skin/v).
%), a precipitate containing the active ingredient is formed, so the precipitate is desalted by, for example, dialysis with a cellulose tube or filtered in an ultra-furnace through a membrane with a molecular weight cutoff of 10,000, and then dried. A brown powder is then obtained.

以上のようにして抽出液を処理することによって、原料
中の活性成分の大部分(場合により90%以上)を回収
することができる。
By treating the extract as described above, most of the active ingredients in the raw materials (90% or more in some cases) can be recovered.

しかし、得られた乾燥粗粉末中の不活性成分の含有量は
凶の方法が最低である。また風の方法は操作が簡単で費
用が安く短時間に行なうことができる。しかも凶の方法
で得られた粗粉末を動物に多量に経口投与しても著しい
副作用は認められないことがわかった。次に、この粗粉
末を、たとえばゲル炉過剤またはイオン交換剤を用いる
カラムクロマトグラフィーのような常法によって精製す
る。
However, the content of inert ingredients in the dry coarse powder obtained is the lowest in the worst method. In addition, the wind method is easy to operate, inexpensive, and can be carried out in a short time. Moreover, it was found that no significant side effects were observed even when a large amount of the coarse powder obtained by the method was orally administered to animals. This crude powder is then purified by conventional methods such as column chromatography using gel filtration agents or ion exchange agents.

ゲル炉過剤を用いた場合は適当な緩衝液で溶出してもよ
いが、通常は水で溶出すればよい。イオン交換剤を用い
た場合は適当な緩衝液で溶出する。実用的なゲル炉過剤
の例は、セフアデックスG−50からG−200まで、
セフアローズ2Bから8Bまで、セフアクリルS一20
0またはS一300(スエーデン国、ファーマシア・フ
ァイン・ケミカルAB製)、バイオゲルP−30力)ら
P−300まで、バイオゲルA(米国、バイオラード・
ラボラトリース製〉、サガバック(英国、セラバック・
ラボラトリース製)等である。イオン交換剤の実用的な
例は、DEAEセフアデツクスA−25およびA−50
(CI−型)、QAEセフアデックスA−25およびA
−50(CI−型)、CMセフアデツクスC−25およ
びC−50(Nが型)、SPセフアデツクスC−25お
よびC−50(Na+型)、DEAEセフアセル(CI
−型)、DEAEセファロースCL−船(CI−型)、
CMセファロースCL一般(Na十型)(スェーデン国
、ファーマシア・ファイン・ケミカルAB製)等である
。適当なアニオンまたはカチオンィオン交換セルロース
を用いて粗粉末を精製することもできる。
When a gel filtration agent is used, elution may be performed with an appropriate buffer, but usually water may be used for elution. If an ion exchange agent is used, elute with an appropriate buffer. Examples of practical gel filter agents are Sephadex G-50 to G-200,
From Sef Arrows 2B to 8B, Sef Acrylic S-20
0 or S-300 (manufactured by Pharmacia Fine Chemical AB, Sweden), Biogel P-30 (manufactured by Pharmacia Fine Chemical AB, Sweden) to P-300, Biogel A (manufactured by Biorad, USA)
Made by Laboratories>, Sagavac (UK, Cerabac)
(manufactured by Laboratories), etc. Practical examples of ion exchangers are DEAE Cephadex A-25 and A-50.
(CI-type), QAE Cephadex A-25 and A
-50 (CI-type), CM Cephadex C-25 and C-50 (N type), SP Cephadex C-25 and C-50 (Na+ type), DEAE Cephacel (CI
- type), DEAE Sepharose CL-ship (CI-type),
CM Sepharose CL general (Na type 10) (manufactured by Pharmacia Fine Chemicals AB, Sweden), etc. The crude powder can also be purified using a suitable anion or cation exchange cellulose.

こうして得られたものは、多少の不純物を含んでいるが
、IF誘起剤として実用することができる。所望により
、上記の精製工程を組合わせることによって、不純物を
さらに除去することもできる。実施例 1 乾燥したベニバナ(Canhamus tinctor
iusLinne)の花(2k9)を水洗した後、水(
40そ)中に常温で3日間放置することにより抽出し、
これを遠心処理(600仇.p.m.、20分間)して
、抽出液と残澄に分け、磯笹を水(各10夕)で2回洗
浄し、洗液を抽出液に合わせた。
Although the product thus obtained contains some impurities, it can be put to practical use as an IF inducer. If desired, impurities can be further removed by combining the above purification steps. Example 1 Dried safflower (Canhamus tinctor)
ius Linne) flowers (2k9) with water, then water (
Extracted by leaving it in a 40-day bath at room temperature for 3 days,
This was centrifuged (600 m.p.m., 20 minutes) to separate the extract and the residual liquid, and the isosasa was washed twice with water (10 min each), and the washing liquid was combined with the extract. .

こうして得られた抽出液をUD‐6型限外炉過器(バイ
オエンジニアリングK.K.、東京)でUK−200限
外炉過膜(分画分子量20方、東洋炉紙社製)を用いて
限外炉過した(圧力3k9′の)。残留物を集めて凍結
乾燥し、褐色粉末(89.46夕)を得た。この粉末(
2夕)を水(5の【)に溶解し、その水溶液をセフアデ
ツクスG一200(フアーマシア・フアイン・ケミカル
AB、スウーデン国)を充填したカラム(4.5×70
肌)に添加し、水(600の【)で溶出し、溶出液を各
3の‘の区分に分け、25亀から5申蚤までの区分を合
わせて凍結乾燥し、白色状粉末(155.04雌)を得
た。さらに精製するために、この粉末(100の夕)を
0.01Mトリスー塩酸緩衝液(pH7.0、1=0.
01)(5の‘)に溶解し、DEAEセフアデツクスA
−50(フアーマシア・フアイン・ケミカルAB、スェ
ーデン国)を充填したカラム(2.5×70弧)に添加
し、0.1Mトリスー塩酸緩衝液(pH9.0、0.9
M食塩を含む、300叫)で綾出し、熔出液を各3の上
の区分に分け、1句電から27番までの区分を合わせた
。この溶液をUK−1叩艮外炉過膜(分画分子量1万、
東洋炉紙社製)を用いた限外炉過により脱塩後、凍結乾
燥し、不定形な白色状粉末(72.3の9)を得た。こ
のものの理化学的および生物学的特性は前記の通りであ
る。これを第1の白色状粉末と比べると、IF譲起活性
はおよそ同じであるが、不純物の量が減少した。高純度
であることが超遠心法および竜気泳動によって確認され
た。比較のために各工程で得られた物質のIF誘起活性
を後記試験例1記載のィン・ビトロ法で測定した結果は
第5表の通りであった。
The extract obtained in this way was passed through a UD-6 type ultrafurnace filter (Bio Engineering K.K., Tokyo) using a UK-200 ultrafurnace membrane (molecular weight cut off: 20, manufactured by Toyo Roshi Co., Ltd.). It was then passed through an ultra-furnace (at a pressure of 3k9'). The residue was collected and lyophilized to give a brown powder (89.46 min.). This powder (
2) was dissolved in water (5), and the aqueous solution was poured into a column (4.5 x 70
The eluate was added to the skin) and eluted with water (600 mm), the eluate was divided into 3 sections each, and the sections from 25 mm to 5 mm were combined and freeze-dried to form a white powder (155 mm). 04 female) was obtained. For further purification, this powder (100 yen) was added to 0.01 M Tris-HCl buffer (pH 7.0, 1=0.
01) (5') and DEAE Sephadex A
-50 (Pharmacia Huain Chemical AB, Sweden) was added to a column (2.5 x 70 arcs) packed with 0.1 M Tris-HCl buffer (pH 9.0, 0.9
The eluate was divided into 3 upper sections, and the 1st to 27th sections were combined. This solution was filtered through a UK-1 filter membrane (molecular weight cut off: 10,000,
After desalting by ultrafiltration using Toyo Roshi Co., Ltd.), the mixture was freeze-dried to obtain an amorphous white powder (72.3-9). The physicochemical and biological properties of this product are as described above. Comparing this to the first white powder, the IF-inducing activity was approximately the same, but the amount of impurities was reduced. High purity was confirmed by ultracentrifugation and aerophoresis. For comparison, the IF-inducing activity of the substances obtained in each step was measured by the in vitro method described in Test Example 1 below, and the results are shown in Table 5.

第5表 実施例 2 乾燥したァレチベニバナ(Ca九hamusla似ta
船Linne)の花(lk9)を水洗した後、これに水
20夕を加え、室温に2時間放置後、10000で2時
間加温抽出した。
Table 5 Example 2 Dried safflower (Ca. hamusla)
After washing the flowers (lk9) of the ship Linne, 20 minutes of water was added thereto, left at room temperature for 2 hours, and then heated and extracted at 10,000 for 2 hours.

その後、実施例1の方法に準じて精製した。この精製物
(70.3の9)の理化学的および生物学的特性は、実
施例1によって得られたものの特性と大差はなかった。
試験例 1 IF誘起剤によるIF譲起の方法およびIF活性の測定
(参考文献:Y.Kojima、Kitasato〜C
h.、Exp.、Med.、43:3il970)‘a
’ィン・ビトロ法による『の誘起方法ウサギ(体重約l
kg、ニュージーランドホワイト種、SPF)を全採血
して殺し、隅豚、骨髄およびリンパ節細胞を採取し、混
合細胞107/泌を含む細胞浮遊液をつくり、各浮遊液
区分(1泌)に、本発明の実施例1記載の方法で得られ
たIF誘起剤10、1、0.1、0.01ムタ/の【を
それぞれ加え、25℃で2独時間培養後、各培養液を遠
心処理してその上燈液をとり、『活性測定用に供した。
Thereafter, it was purified according to the method of Example 1. The physicochemical and biological properties of this purified product (70.3-9) were not significantly different from those obtained in Example 1.
Test Example 1 Method of IF induction using IF inducer and measurement of IF activity (Reference: Y. Kojima, Kitasato-C
h. , Exp. , Med. , 43:3il970)'a
``How to induce ``by in vitro method'' Rabbit (body weight approx.
kg, New Zealand White breed, SPF) were whole bled and sacrificed, corner pigs, bone marrow and lymph node cells were collected, a cell suspension containing 107 mixed cells/secretion was made, and in each suspension section (1 secretion), After adding 10, 1, 0.1, and 0.01 muta/ml of the IF inducer obtained by the method described in Example 1 of the present invention, and culturing at 25°C for 2 hours, each culture solution was centrifuged. Then, remove the light solution and use it for activity measurement.

(b} ィン・ビボ法による『の誘起方法実施例1記載
の方法で得られたIF誘起剤の水溶液(500ムタ/協
)2私をウサギ(体重約lk9、ニュージーランドホワ
イト種、SPF)の耳静脈に注射し、1、2、4、6時
間後に採血(2地)し、その血清をIF活性測定用に供
した。
(b) Method for inducing IF by in vivo method Aqueous solution of IF inducer obtained by the method described in Example 1 (500 muta/co) Blood was collected at 2 sites 1, 2, 4, and 6 hours after the injection into the ear vein, and the serum was used for IF activity measurement.

‘c} IF活性の測定 上記{a}(bー法ともに、産生された『活性の測定は
、ウサギ腎株化細胞(RK−13)を用いた50%ブラ
ック半減法で行なわれる。
'c} Measurement of IF activity In both the above {a} (b-methods), the produced 'activity is measured by the 50% black half-life method using rabbit kidney established cell line (RK-13).

まず予めシャーレに準備しておいた上記細砲の単層培養
上に、上記【机b}法で得られた適当に稀釈した『試料
溶液を加え、37o0で1夜培養後、水庖性口内炎ウイ
ルス(Vesic山arstomatitisvir瓜
)を攻撃用ウイルスとし、そのブラックの減少率を指標
としてIF活性を測定した。なお、IF活性の単位はI
F無処置細胞におけるブラック数の50%を示す稀釈の
逆数として表現される。試験例 2IF誘起剤であるこ
との証明方法 上記‘秋b}の方法で産生されたIF試料は、同動物種
のウサギRK−1孫曲胞上で水庖性口内炎ウイルスの増
殖を抑制するほか、ワクシニアウィルス(Vaccin
iavims)の増檀も抑制するが、動物菌の異なるマ
ウスのL細胞では水庖性口内炎ウイルスの増殖を抑制し
ない。
First, on a monolayer culture of the above-mentioned cannons prepared in advance in a Petri dish, the appropriately diluted sample solution obtained by the above [Table B] method was added, and after culturing overnight at 37°C, A virus (Vesic arstomatis viridis) was used as a challenge virus, and the IF activity was measured using the black reduction rate as an index. Note that the unit of IF activity is I
F is expressed as the reciprocal of the dilution representing 50% of the black number in untreated cells. Test Example 2 Method for proving that it is an IF inducer The IF sample produced by the method of 'Autumn b' above inhibits the proliferation of varicella stomatitis virus on rabbit RK-1 grand follicles of the same animal species. , vaccinia virus (Vaccinia virus)
iavims), but does not inhibit the proliferation of varicella stomatitis virus in L cells of mice with different animal bacteria.

また0.08%トリブシンを370で2時間作用させる
と、そのIF活性は失活する。試験例 3 露気泳動 鏡気泳動は東洋科学産業■製(東京)の装置(AE一Z
型)を用い、厚さ3肌のポリアクリルアマィドゲルのプ
レートと0.3Mホウ酸緩衝液(冊8.4)とを用いて
行なった。
Furthermore, when 0.08% tribucin is applied at 370° C. for 2 hours, the IF activity is inactivated. Test Example 3 Dew air phoresis and spectrophoresis were performed using a device (AE-Z) manufactured by Toyo Kagaku Sangyo (Tokyo).
The test was carried out using a polyacrylamide gel plate with a thickness of 3 cm and 0.3 M borate buffer (Book 8.4).

その結果、単一のバンドを示し、電気漆動的に本発明の
物質が均一であることが認められた。
As a result, a single band was observed, and it was confirmed that the material of the present invention was electrolytically uniform.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明による物質の紫外線吸収スペクトル、第
2図は赤外線吸収スペクトルを示す。 第2図第1図
FIG. 1 shows the ultraviolet absorption spectrum of the material according to the invention, and FIG. 2 shows the infrared absorption spectrum. Figure 2 Figure 1

Claims (1)

【特許請求の範囲】 1 キク科(Compositae)ベニバナ属(Ca
rthamus)に属しかつインターフエロン誘起活性
物質を含有する植物またはその変員の組織から上記活性
物質を抽出し、抽出物からこれを回収することを特徴と
するインターフエロン誘起剤の製法。 2 抽出液に親水性有機溶剤を加えることにより活性物
質を回収する特許請求の範囲第1項による方法。 3 抽出液にアンモニウム塩または無機金属塩を加える
ことにより活性物質を回収する特許請求の範囲第1項に
よる方法。 4 水性抽出液から限外濾過によって活性物質を回収す
る特許請求の範囲第1項による方法。
[Scope of Claims] 1. Compositae, genus Safflower (Ca
1. A method for producing an interferon-inducing agent, which comprises extracting the active substance from a tissue of a plant or a variant thereof belonging to the genus P. rthamus and containing the interferon-inducing active substance, and recovering the active substance from the extract. 2. A method according to claim 1, in which the active substance is recovered by adding a hydrophilic organic solvent to the extract. 3. A method according to claim 1, in which the active substance is recovered by adding an ammonium salt or an inorganic metal salt to the extract. 4. A method according to claim 1 for recovering active substances from an aqueous extract by ultrafiltration.
JP54013024A 1979-02-07 1979-02-07 Method for producing interferon inducer Expired JPS6011892B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP54013024A JPS6011892B2 (en) 1979-02-07 1979-02-07 Method for producing interferon inducer
DE19803004018 DE3004018A1 (en) 1979-02-07 1980-02-05 SUBSTANCE WITH INTERFERON INDUCING ACTIVITY AND METHOD FOR THEIR PRODUCTION
BE0/199303A BE881595A (en) 1979-02-07 1980-02-07 INTERFERON INDUCER AND MANUFACTURING METHOD THEREOF
GB8004156A GB2042558B (en) 1979-02-07 1980-02-07 Interferon inducers methods for their preparation pharmaceutical compositions containing them and their use as medicaments
FR8002649A FR2448350A1 (en) 1979-02-07 1980-02-07 INTERFERON INDUCER AND MANUFACTURING METHOD THEREOF
IN144/CAL/81A IN152883B (en) 1979-02-07 1981-02-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54013024A JPS6011892B2 (en) 1979-02-07 1979-02-07 Method for producing interferon inducer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP59178143A Division JPS6069024A (en) 1984-08-27 1984-08-27 Interferon-inducing substance

Publications (2)

Publication Number Publication Date
JPS55115893A JPS55115893A (en) 1980-09-06
JPS6011892B2 true JPS6011892B2 (en) 1985-03-28

Family

ID=11821563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54013024A Expired JPS6011892B2 (en) 1979-02-07 1979-02-07 Method for producing interferon inducer

Country Status (3)

Country Link
JP (1) JPS6011892B2 (en)
BE (1) BE881595A (en)
IN (1) IN152883B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6411034B2 (en) * 2013-06-06 2018-10-24 三栄源エフ・エフ・アイ株式会社 Method for analysis of proteins in natural acid pigments
JP6338928B2 (en) * 2014-05-21 2018-06-06 三栄源エフ・エフ・アイ株式会社 Quantitative analysis of protein in cochineal dye

Also Published As

Publication number Publication date
BE881595A (en) 1980-08-07
IN152883B (en) 1984-04-21
JPS55115893A (en) 1980-09-06

Similar Documents

Publication Publication Date Title
EP0893449B1 (en) Antitumor substance extracted from hen-of-the-woods
JP2651674B2 (en) New physiologically active substance and method for producing the same
EP0030812B1 (en) A process for preparing substances having interferon inducing activity and interferon inducers
JPS5896025A (en) Novel physiologically active substance ch-1 and its preparation
DE69315388T2 (en) Extract consisting of bacterial proteins, process for its preparation and pharmaceutical composition containing this extract
DE3230151A1 (en) NEW POLYPEPTIDE WITH EFFECT ON THE IMMUNE SYSTEM, METHOD FOR ITS INSULATION AND CLEANING, ITS USE, ITS CONTAINER, AND ITS DIFFERENT PRODUCTS, THEIR USE AND ITEMS
RU2163266C2 (en) Proteins rich in hydroxyproline and cosmetic preparative forms containing them
DE2919132A1 (en) SUBSTANCE KS-2-B, PROCESS FOR THEIR PRODUCTION AND MEANS CONTAINING THIS SUBSTANCE
CA2035948A1 (en) Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them
JPS6011892B2 (en) Method for producing interferon inducer
Khan et al. Partial characterisation of an induced virus inhibitory protein, associated with systemic resistance in Cyamopsis tetragonoloba (L.) Taub. plants
JPS601282B2 (en) Method for producing interferon inducer
JPS6152807B2 (en)
JPS6011891B2 (en) Method for producing interferon inducer
GB2042555A (en) Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
CA1105863A (en) Biologically active substance
JPS6069023A (en) Interferon-inducing substance
JPS625407B2 (en)
JPS6069024A (en) Interferon-inducing substance
JPS61209599A (en) Production of polysaccharide by tissue culture
DE3004018C2 (en)
JPS6013004B2 (en) Production method of interferon inducer
EP0125892B1 (en) Islets-activating protein derivatives
JPS5940135B2 (en) Polymer polysaccharide based on 1-3 linked glucose having interferon-inducing activity and method for producing the same
JPS6152806B2 (en)